News Sentiment

AVIR sentiment intelligence

Atea Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 30 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.99 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 22

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

+0.2% over one week, +11.1% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Atea Pharmaceuticals Begins Phase 1 Clinical Trial of Potential Hepatitis E Treatment

Market Reaction

Balanced read

50/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction 0.2% Price digesting
Trend fit Trend inactive 11.1% over four weeks
Fair value 38.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 26
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 22
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
GlobeNewswire 4
simplywall.st 4
Stock Titan 3
MT Newswires 2
Zacks 2
DonanımHaber 1
TradingKey 1

Event Lens

What the news is about

Classified themes
Market update 16
Earnings 12
Analyst action 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 30